Bayer Recalls Nearly 800,000 Bottles of Afrin Nasal Spray — Packaging Poses Poisoning Risk for Young Children

Bayer has pulled nearly 800,000 travel-size bottles of Afrin Original Nasal Spray from the market after federal regulators found that the packaging does not meet child-resistant standards required by law. The U.S. Consumer Product Safety Commission announced the voluntary recall on April 30, 2026, covering approximately 786,100 six-milliliter bottles sold primarily at convenience stores and airport travel shops across the country.

The concern is straightforward: these bottles can be opened by young children, and the active ingredient inside — oxymetazoline — is dangerous enough that even a small amount can send a child to the emergency room.

What Was Recalled

The recall covers travel-size Afrin Original Nasal Spray 6 mL bottles with the following lot numbers printed on the packaging:

• 230361
• 240822
• 241198
• 250066
• 250152
• 250646
• 250831

These bottles were not sold at major retailers like Walmart, Target, or Amazon. They were distributed specifically through convenience stores and travel locations such as airport shops and hotel gift stores. They were on shelves from September 2024 through April 2026, priced at roughly $7 to $9 each.

If you bought a small bottle of Afrin at an airport, a gas station, or a convenience store during that period, check the lot number before using it again.

What Makes This Dangerous

The active ingredient in Afrin is oxymetazoline, which belongs to a class of drugs called imidazolines. These medications work well for adults to relieve nasal congestion, but they are a very different story for young children.

• If a young child swallows even a small amount, it can cause serious medical problems including low blood pressure, difficulty breathing, and loss of consciousness.
• Federal law requires that medications like this be sold in child-resistant packaging — these bottles were not.
• The bottles also lack the required front-label warning statement about child safety.
• No injuries have been reported yet. But the risk is real: imidazoline-type medications are a leading cause of emergency room visits for accidental poisoning in young children.

Federal rules under the Poison Prevention Packaging Act exist precisely because medications that can seriously harm children need barriers between curious little hands and the contents inside. These bottles did not have those barriers.

What to Do Right Now

If you have any travel-size Afrin at home, in your car, or in a travel bag, take a few minutes to check it now:

• Check your medicine cabinet, travel bag, and car for any travel-size Afrin 6 mL bottles.
• Check the lot number on the bottle — if it matches one of the listed lot numbers above, stop using it immediately.
• Secure the bottle right away, completely out of sight and reach of children.
• Visit www.livewell.bayer.com/afrin-original-spray-recall to request a refund — you will need to submit a photo of the product through Bayer’s recall portal.
• Do not throw the bottle away before submitting for your refund, if possible — the photo is required to process it.

The refund process is free. You do not need a receipt. Bayer is handling the recall directly through its Livewell portal.

If Your Child Was Hurt

If a child swallowed any Afrin or similar nasal spray and showed symptoms — drowsiness, limpness, low heart rate, pale skin, or trouble breathing — call 911 or Poison Control (1-800-222-1222) immediately. These symptoms can come on quickly and escalate fast.

If your child was seriously injured after accessing a non-child-resistant medication, you may have the right to pursue a case. When a company puts a product on the market in packaging that does not meet federal safety requirements, and a child is hurt as a result, that company can be held responsible — even if the packaging failure was said to be unintentional.

Why Packaging Standards Exist — And What Happens When They’re Broken

Federal law under the Poison Prevention Packaging Act requires child-resistant packaging for products that can seriously harm young children. These rules exist because children are naturally curious and will try to open anything they can reach — and they are fast about it.

The law does not give companies a pass just because a packaging failure was accidental. When a company sells a product in packaging that does not meet those standards, it creates legal responsibility if a child is hurt. Courts across the country have applied this principle consistently: the standard exists, and companies are expected to follow it.

A free review can help you understand whether an injury in your family gives you legal options. There is no cost to check, and no obligation to move forward.